首页> 外国专利> USE OF ALPHAvBi3 ANTAGONIST FOR PREPARING A MEDICAMENT FOR PREVENTION, INHIBITION AND TREATING ANGIOGENESIS IN A TISSUE, REGRESSION OF DEVELOPED TUMOR IN A TISSUE OR APOPTOSE INDUCTION IN NEOVASCULAR TISSUE

USE OF ALPHAvBi3 ANTAGONIST FOR PREPARING A MEDICAMENT FOR PREVENTION, INHIBITION AND TREATING ANGIOGENESIS IN A TISSUE, REGRESSION OF DEVELOPED TUMOR IN A TISSUE OR APOPTOSE INDUCTION IN NEOVASCULAR TISSUE

机译:ALPHAvBi3拮抗剂在制备预防,抑制和治疗组织血管生成,肿瘤在组织或肿瘤中诱导凋亡的药物的治疗中的应用

摘要

In the present invention, there is disclosed the use of {alpha}iv{beta}i3 antagonists in the preparation of a medicament intended for treating arthritis, diabetic retinopathy, macular degeneration, restenosis, hemangioma or solid tumor of lung, pancreas, breast, colon, larynx or ovary.
机译:在本发明中,公开了αiv{beta} i3拮抗剂在制备用于治疗关节炎,糖尿病性视网膜病,黄斑变性,再狭窄,血管瘤或肺,胰腺,乳腺实体瘤的药物中的用途。结肠,喉或子房。

著录项

  • 公开/公告号CZ9602711A3

    专利类型

  • 公开/公告日1998-01-14

    原文格式PDF

  • 申请/专利权人 THE SCRIPPS RESEARCH INSTITUTE;

    申请/专利号CZ19960002711

  • 发明设计人 BROOKS PETER;CHERESH DAVID A.;

    申请日1995-03-09

  • 分类号A61K39/395;C07K16/00;C07K16/18;C07K16/28;C07K16/30;

  • 国家 CZ

  • 入库时间 2022-08-22 02:58:22

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号